Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product

BACKGROUND: Existence of anti-malarial generic drugs with low bioavailability marketed on sub-Saharan Africa raises a concern on patients achieving therapeutic concentrations after intake of such products. This work compared bioavailability of one generic tablet formulation with innovator’s product....

Descripción completa

Detalles Bibliográficos
Autores principales: Minzi, Omary MS, Marealle, Ignace A, Shekalaghe, Seif, Juma, Omar, Ngaimisi, Eliford, Chemba, Mwajuma, Rutaihwa, Mastidia, Abdulla, Salim, Sasi, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669611/
https://www.ncbi.nlm.nih.gov/pubmed/23718725
http://dx.doi.org/10.1186/1475-2875-12-174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669611/
https://www.ncbi.nlm.nih.gov/pubmed/23718725
http://dx.doi.org/10.1186/1475-2875-12-174

Ejemplares similares